QA: Cellectar Biosciences Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2021_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 57,939,809
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 355,982
3 remainder_Assets 363,579
4 LiabilitiesCurrent 3,563,101
5 LiabilitiesNoncurrent 301,740
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,160,702
9 ResearchAndDevelopmentExpense 9,735,496
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 200,491
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 58,659,370
1 Liabilities 3,864,841
2 Expenses 14,896,198
3 Revenues 0
4 StockholdersEquity 54,794,529
5 NetIncome -14,695,707
6 ComprehensiveNetIncome -14,695,707
7 BaseVar 38,810,450
8 EconomicCapitalRatiobeforeLimitedLiability 3.35
9 EconomicCapitalRatio 3.93

Edgar->Model Mapping

Feature Distribution

Change over Time